Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women.

Abdool Karim, Quarraisha, Abdool Karim, Salim S., Frohlich, Janet A., Grobler, Anneke C., Baxter, Cheryl, Mansoor, Leila E., Kharsany, Ayesha B. M., Sibeko, Sengeziwe +9 more·2010·Science

DOI 10.1126/science.1193748

Cited by (1,005)

Items 101–200 of 1,005

Polymer-based nanocarriers for vaginal drug delivery
das Neves, José, Nunes, Rute, Machado, Alexandra, Sarmento, Bruno · 2015 · Advanced Drug Delivery Reviews
Changes in renal function associated with oral emtricitabine/tenofovir disoproxil fumarate use for HIV pre-exposure prophylaxis
Marc M. Solomon, Javier R. Lama, David V. Glidden, Kathleen M. Mulligan, Vanessa McMahan, Albert Liu, Juan V. Guanira, Valdilea Gonçalves Veloso, Kenneth Hugh Mayer, Suwat Chariyalertsak et al. · 2014 · AIDS
One Percent Tenofovir Applied Topically to Humanized BLT Mice and Used According to the CAPRISA 004 Experimental Design Demonstrates Partial Protection from Vaginal HIV Infection, Validating the BLT Model for Evaluation of New Microbicide Candidates
Paul W. Denton, Florence A. Othieno, Francisco J. Martinez-Torres, Wei Zou, John F. Krisko, Elisa H. Fleming, Sima Zein, Daniel A. Powell, Angela R. Wahl, Youn Tae Kwak et al. · 2011 · Journal of Virology
Preconception care: delivery strategies and packages for care
Z. Lassi, S. Dean, Dania Mallick, Z. Bhutta · 2014 · Reproductive Health
Neutralizing antibodies to HIV-1 induced by immunization
Laura E. McCoy, Robin A. Weiss · 2013 · The Journal of Experimental Medicine
HIV epidemiology, prevention, treatment, and implementation strategies for public health
Aaloke Mody, Annette H. Sohn, Collins C. Iwuji, Rayner Kay Jin Tan, François Venter, Elvin Geng · 2023 · The Lancet
Sexual Risk Behavior Among HIV-Uninfected Men Who Have Sex With Men Participating in a Tenofovir Preexposure Prophylaxis Randomized Trial in the United States
Albert Liu, Eric Vittinghoff, Kata L. Chillag, Kenneth Hugh Mayer, Melanie Thompson, Lisa A. Grohskopf, Grant Nash Colfax, Sonal Pathak, Roman J. Gvetadze, Brandon M. O'Hara et al. · 2013 · JAIDS Journal of Acquired Immune Deficiency Syndromes
A distinct cytokine and chemokine profile at the genital mucosa is associated with HIV-1 protection among HIV-exposed seronegative commercial sex workers
Julie Lajoie, Jennifer A. Juno, Adam Burgener, Syeda Masooma Rahman, Kenzie Mogk, Charles Wachihi, J Mwanjewe, Frank A. Plummer, Joshua Kimani, Terry Blake Ball et al. · 2012 · Mucosal Immunology
Systematic identification of synergistic drug pairs targeting HIV
Xu Tan, Long Hu, Lovelace J. Luquette, Geng Gao, Yifang Liu, Hongjing Qu, Ruibin Xi, Zhi John Lu, Peter J. Park, Stephen Joseph Elledge · 2012 · Nature Biotechnology
RMP-02/MTN-006: A Phase 1 Rectal Safety, Acceptability, Pharmacokinetic, and Pharmacodynamic Study of Tenofovir 1% Gel Compared with Oral Tenofovir Disoproxil Fumarate
Peter A. Anton, Ross Cranston, Angela D. M. Kashuba, Craig W. Hendrix, Namandjé N. Bumpus, Nicola Richardson‐Harman, Julie E. Elliott, Laura E. Janocko, Elena Khanukhova, Robert Dennis et al. · 2012 · AIDS Research and Human Retroviruses
Antiretroviral pre-exposure prophylaxis (PrEP) for preventing HIV in high-risk individuals
Charles I Okwundu, Christy A. N. Okoromah · 2009 · Cochrane Database of Systematic Reviews
Importance of Drug Pharmacokinetics at the Site of Action
Matthew L. Rizk, Ling Zou, Radojka M. Savić, Kelly E. Dooley · 2017 · Clinical and Translational Science
In vivo distribution of surface-modified PLGA nanoparticles following intravaginal delivery
Cu, Yen, Booth, Carmen J., Saltzman, W. Mark · 2011 · Journal of Controlled Release
The clinical potential of the acyclic (and cyclic) nucleoside phosphonates. The magic of the phosphonate bond
Erik De Clercq · 2011 · Biochemical Pharmacology
Anti-HIV-1 Activity of Flavonoid Myricetin on HIV-1 Infection in a Dual-Chamber In Vitro Model
Silvana Pasetto, Vanessa Pardi, Ramiro Mendonça Murata · 2014 · PLoS ONE
Antiretrovirals and safer conception for HIV-serodiscordant couples
Lynn T. Matthews, Jennifer A. Smit, Susan Cu‐Uvin, Deborah Cohan · 2012 · Current Opinion in HIV and AIDS
Human immunodeficiency virus (HIV) immunopathogenesis and vaccine development: A review
Marc P Girard, Saladin Osmanov, Olga M. Assossou, Marie-Paule Kiény · 2011 · Vaccine
Case report: mechanisms of HIV elite control in two African women
Yumna Moosa, Ramla Fatime Tanko, Veron Ramsuran, Ravesh Singh, Mashudu Madzivhandila, Nonhlanhla Yende‐Zuma, Melissa-Rose Abrahams, Philippe Selhorst, Kamini Gounder, Penny L. Moore et al. · 2018 · BMC Infectious Diseases
Ratio of Monocytes to Lymphocytes in Peripheral Blood Identifies Adults at Risk of Incident Tuberculosis Among HIV-Infected Adults Initiating Antiretroviral Therapy
Vivek Naranbhai, Adrian V. S. Hill, Salim S. Abdool Karim, Kogieleum Naidoo, Quarraisha Abdool Karim, George M. Warimwe, Helen McShane, Helen A. Fletcher · 2013 · The Journal of Infectious Diseases
Drug-Eluting Fibers for HIV-1 Inhibition and Contraception
Cameron Scott Ball, Emily A. Krogstad, Thanyanan Chaowanachan, Kim A. Woodrow · 2012 · PLoS ONE
Perspectives on use of oral and vaginal antiretrovirals for HIV prevention: the VOICE‐C qualitative study in Johannesburg, South Africa
Ariane van der Straten, Jonathan Stadler, Ellen H. Luecke, Nicole D. Laborde, Miriam Hartmann, Elizabeth Montgomery, VOICE‐C Study Team · 2014 · Journal of the International AIDS Society
Use of a Rapid HIV Home Test Prevents HIV Exposure in a High Risk Sample of Men Who Have Sex With Men
Alex Carballo‐Diéguez, Timothy Frasca, Iván C. Balán, Mobolaji Ibitoye, Curtis L. Dolezal · 2012 · AIDS and Behavior
pH-responsive nanoparticles releasing tenofovir intended for the prevention of HIV transmission
Tao Zhang, Timothy F. Sturgis, Bi-Botti Celestin Youan · 2011 · European Journal of Pharmaceutics and Biopharmaceutics
The rise and fall of polyanionic inhibitors of the human immunodeficiency virus type 1
Vanessa Pirrone, Brian L. Wigdahl, Fred C. Krebs · 2011 · Antiviral Research
Phase 1 randomized trial of the vaginal safety and acceptability of SPL7013 gel (VivaGel) in sexually active young women (MTN-004)
Ian McGowan, Kailazarid Gomez, Karen Bruder, Irma L. Febo, Beatrice A. Chen, Barbra A. Richardson, Marla J. Husnik, Edward Livant, Clare F. Price, Cindy E. Jacobson · 2011 · AIDS
Recomendaciones de Gesida/Plan Nacional sobre el Sida respecto al tratamiento antirretroviral en adultos infectados por el virus de la inmunodeficiencia humana (actualización febrero de 2009)
Panel de expertos de Gesida, Plan Nacional sobre el Sida · 2009 · Enfermedades Infecciosas y Microbiología Clínica
Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-blind, phase 3 trial
Jared M. Baeten, Deborah J Donnell, Nelly Mugo, Patrick Ndase, Katherine K. Thomas, James D. Campbell, Jonathan Wangisi, Jordan W. Tappero, Elizabeth Anne Bukusi, Craig R. Cohen et al. · 2014 · The Lancet Infectious Diseases
Financing of HIV/AIDS programme scale-up in low-income and middle-income countries, 2009–31
Robert Hecht, John Stover, Lori A Bollinger, Farzana Muhib, Kelsey K. Case, David de Ferranti · 2010 · The Lancet
Intimate Partner Violence and Adherence to HIV Pre-exposure Prophylaxis (PrEP) in African Women in HIV Serodiscordant Relationships: A Prospective Cohort Study
Sarah T. Roberts, Jessica Elizabeth Haberer, Connie Celum, Nelly Mugo, Norma C. Ware, Craig R. Cohen, Jordan W. Tappero, James Njogu Kiarie, Allan Ronald, Andrew Mujugira et al. · 2016 · JAIDS Journal of Acquired Immune Deficiency Syndromes
Development of broadly neutralizing antibodies in HIV-1 infected elite neutralizers
Elise Landais, Penny L. Moore · 2018 · Retrovirology
Topical Tenofovir, a Microbicide Effective against HIV, Inhibits Herpes Simplex Virus-2 Replication
Graciela Andreï, Andrea Lisco, Christophe Vanpouille, Andrea Introini, Emanuela Balestra, Joost van den Oord, Tomáš Cihlář, Carlo Federico Perno, Robert Snoeck, Leonid B Margolis et al. · 2011 · Cell Host & Microbe
Adherence to Preexposure Prophylaxis: Current, Emerging, and Anticipated Bases of Evidence
K. Rivet Amico, Michael J. Stirratt · 2014 · Clinical Infectious Diseases
Preexposure prophylaxis-related stigma: strategies to improve uptake and adherence – a narrative review
Bridget Gabrielle Haire · 2015 · HIV/AIDS - Research and Palliative Care
Microbicides: Topical Prevention against HIV
Robin J. Shattock, Zeda Rosenberg · 2011 · Cold Spring Harbor Perspectives in Medicine
Polymeric gels for intravaginal drug delivery
Michael Thomas Cook, Marc B. Brown · 2017 · Journal of Controlled Release
Potent and broad neutralization of HIV-1 by a llama antibody elicited by immunization
Laura E. McCoy, Anna Forsman Quigley, Nika M. Strokappe, Bianca Bulmer‐Thomas, Michael S. Seaman, Daniëlla Mortier, Lucy Rutten, Nikita R Chander, Carolyn Edwards, Robin Ketteler et al. · 2012 · The Journal of Experimental Medicine
Daily and non-daily pre-exposure prophylaxis in African women (HPTN 067/ADAPT Cape Town Trial): a randomised, open-label, phase 2 trial
Linda‐Gail Bekker, Surita Roux, Elaine Sebastien, Ntando Yola, K. Rivet Amico, James P. Hughes, Mark A. Marzinke, Craig W. Hendrix, Peter L. Anderson, Vanessa Elharrar et al. · 2017 · The Lancet HIV
Vaginal microbiota and susceptibility to HIV
McKenna C. Eastment, Raymond Scott McClelland · 2018 · AIDS
Polymer nanoparticles encapsulating siRNA for treatment of HSV-2 genital infection
Steinbach, Jill M., Weller, Caroline E., Booth, Carmen J., Saltzman, W. Mark · 2012 · Journal of Controlled Release
Is Wetter Better? An Evaluation of Over-the-Counter Personal Lubricants for Safety and Anti-HIV-1 Activity
Charlene S. Dezzutti, Elizabeth R. Brown, Bernard J. Moncla, Julie Russo, Marilyn R. Cost, Lin Wang, Kevin Uranker, Ratiya Pamela Kunjara Na Ayudhya, Kara M. Pryke, Jim Pickett et al. · 2012 · PLoS ONE
Safety, Acceptability and Adherence of Dapivirine Vaginal Ring in a Microbicide Clinical Trial Conducted in Multiple Countries in Sub-Saharan Africa
Annalene M. Nel, Linda‐Gail Bekker, Elizabeth Anne Bukusi, Elizabeth Hellström, Philip L. Kotze, Cheryl Emily Louw, Francis E. A. Martinson, Gileard Gabriel Masenga, Elizabeth Montgomery, Nelisiwe Dorcas. Ndaba et al. · 2016 · PLoS ONE
A Phase 1 Randomized, Double Blind, Placebo Controlled Rectal Safety and Acceptability Study of Tenofovir 1% Gel (MTN-007)
Ian McGowan, Craig J. Hoesley, Ross Cranston, P. Andrew, Laura E. Janocko, James Y. Dai, Alex Carballo‐Diéguez, Ratiya Pamela Kunjara Na Ayudhya, Jeanna M. Piper, Florian Hladik et al. · 2013 · PLoS ONE
Identifying At-Risk Populations in Kenya and South Africa
Matt A. Price, WASIMA N. RIDA, Mary N. Mwangome, Gaudensia Nzembi Mutua, Keren Middelkoop, Surita Roux, Haile Selassie Okuku, Linda‐Gail Bekker, Omu Aggrey Anzala, ELIZABETH N. NGUGI et al. · 2012 · JAIDS Journal of Acquired Immune Deficiency Syndromes
Griffithsin Protects Mice from Genital Herpes by Preventing Cell-to-Cell Spread
Briana G. Nixon, Martha Stefanidou, Pedro M. M. Mesquita, Esra Fakioglu, Theodore J. Segarra, Lisa Cencia Rohan, William P. Halford, Kenneth E. Palmer, Betsy C. Herold · 2013 · Journal of Virology
Preventing HIV Among Young People
Audrey E. Pettifor, Linda‐Gail Bekker, Sybil Hosek, Ralph Joseph DiClemente, Molly S. Rosenberg, Sheana Salyers Bull, Susannah M. Allison, Sinéad Delany‐Moretlwe, Bill G. Kapogiannis, Frances Mary Cowan · 2013 · JAIDS Journal of Acquired Immune Deficiency Syndromes
Complex immune correlates of protection in HIV ‐1 vaccine efficacy trials
Georgia D. Tomaras, Stanley Alan Plotkin · 2017 · Immunological Reviews
Facilitators and barriers to medication adherence in an HIV prevention study among men who have sex with men in the iPrEx study in Chiang Mai, Thailand
Arunrat Tangmunkongvorakul, Suwat Chariyalertsak, K. Rivet Amico, Pongpun Saokhieo, Vorawan Wannalak, Thirayut Sangangamsakun, Pedro Goicochea, Robert M. Grant · 2012 · AIDS Care
Dual HIV risk and vulnerabilities among women who use or inject drugs
Nabila El‐Bassel, Wendee M. Wechsberg, Stacey A. Shaw · 2012 · Current Opinion in HIV and AIDS
Manipulating biological agents and cells in micro-scale volumes for applications in medicine
Savaş Taşoğlu, Umut Atakan Gurkan, Shuqi Wang, Utkan Demirci · 2013 · Chemical Society Reviews
Prevention of HIV in Adolescent Girls and Young Women: Key to an AIDS-Free Generation
Quarraisha Abdool Karim, Cheryl Baxter, Deborah L. Birx · 2017 · JAIDS Journal of Acquired Immune Deficiency Syndromes
The interconnections between maternal and newborn health – evidence and implications for policy
Zohra S Lassi, Amara Majeed, Shafia Rashid, Mohammad Yawar Yakoob, Zulfiqar Ahmed Bhutta · 2013 · The Journal of Maternal-Fetal & Neonatal Medicine
Development and characterization of a vaginal film containing dapivirine, a non-nucleoside reverse transcriptase inhibitor (NNRTI), for prevention of HIV-1 sexual transmission
Ayman Akil, Michael A. Parniak, Charlene S. Dezzutti, Bernard J. Moncla, Marilyn R. Cost, Mingguang Li, Lisa Cencia Rohan · 2011 · Drug Delivery and Translational Research
An Information–Motivation–Behavioral Skills Model of PrEP Uptake
Alex Dubov, Frederick Lewis Altice, Liana Fraenkel · 2018 · AIDS and Behavior
Phase 1 Safety, Pharmacokinetics, and Pharmacodynamics of Dapivirine and Maraviroc Vaginal Rings
Beatrice A. Chen, Lori Panther, Mark A. Marzinke, Craig W. Hendrix, Craig J. Hoesley, Ariane van der Straten, Marla J. Husnik, Lydia E Soto-Torres, Annalene M. Nel, Sherri Johnson et al. · 2015 · JAIDS Journal of Acquired Immune Deficiency Syndromes
Tailored combination prevention packages and PrEP for young key populations
Audrey E. Pettifor, Nadia Nguyen, Connie Celum, Frances Mary Cowan, Vivian Fei-ling Go, Lisa Hightow‐Weidman · 2015 · Journal of the International AIDS Society
Will Gay and Bisexually Active Men at High Risk of Infection Use Over-the-Counter Rapid HIV Tests to Screen Sexual Partners?
Alex Carballo‐Diéguez, Timothy Frasca, Curtis L. Dolezal, Iván C. Balán · 2012 · The Journal of Sex Research
Intravaginal ring eluting tenofovir disoproxil fumarate completely protects macaques from multiple vaginal simian-HIV challenges
James M. Smith, Rachna Rastogi, Ryan S. Teller, Priya Srinivasan, Pedro M. M. Mesquita, Umadevi Nagaraja, Janet M. McNicholl, R. Michael Hendry, Chuong T. Dinh, Amy M. Martin et al. · 2013 · Proceedings of the National Academy of Sciences
Targeting the C-type Lectins-Mediated Host-Pathogen Interactions with Dextran
Sergei Pustylnikov, Divya Sagar, Pooja Jain, Zafar K. Khan · 2014 · Journal of Pharmacy & Pharmaceutical Sciences
Sexual behaviour of heterosexual men and women receiving antiretroviral pre-exposure prophylaxis for HIV prevention: a longitudinal analysis
Kenneth K. Mugwanya, Deborah J Donnell, Connie Celum, Katherine K. Thomas, Patrick Ndase, Nelly Mugo, Elly Tebasoboke Katabira, Kenneth Ngure, Jared M. Baeten · 2013 · The Lancet Infectious Diseases
Sustained Delivery of a Broadly Neutralizing Antibody in Nonhuman Primates Confers Long-Term Protection against Simian/Human Immunodeficiency Virus Infection
Kevin O. Saunders, Amarendra Pegu, Ivelin S. Georgiev, Ming Zeng, Michael Gordon Joyce, Zhiyong Yang, Sung‐Youl Ko, Xuejun Chen, Stephen D. Schmidt, Ashley T. Haase et al. · 2015 · Journal of Virology
Depot Medroxyprogesterone Acetate Increases Immune Cell Numbers and Activation Markers in Human Vaginal Mucosal Tissues
Neelima Chandra, Andrea Ries Thurman, Sharon M. Anderson, Tina Duong Cunningham, Nazita Yousefieh, Christine K. Mauck, Gustavo F. Doncel · 2012 · AIDS Research and Human Retroviruses
Distinct HIV discordancy patterns by epidemic size in stable sexual partnerships in sub-Saharan Africa
Hiam S. Chemaitelly, Íde Cremin, Jim Shelton, Timothy B. Hallett, Laith Jamal Abu-Raddad · 2012 · Sexually Transmitted Infections
Durable Protection from Vaginal Simian-Human Immunodeficiency Virus Infection in Macaques by Tenofovir Gel and Its Relationship to Drug Levels in Tissue
Charles Dobard, Sunita Sharma, Amy Martin, Chou‐Pong Pau, Angela N. Holder, Zsuzsanna Kuklenyik, Jonathan T. Lipscomb, Debra L. Hanson, James M. Smith, Francis J. Novembre et al. · 2011 · Journal of Virology
Microbicide vaginal rings: Technological challenges and clinical development
Karl R. Malcolm, Peter J. Boyd, Clare F. McCoy, Diarmaid J. Murphy · 2016 · Advanced Drug Delivery Reviews
HIV Prevention Interventions for Adolescents
Sybil Hosek, Audrey E. Pettifor · 2019 · Current HIV/AIDS Reports
Infectious Co-Factors in HIV-1 Transmission Herpes Simplex Virus Type-2 and HIV-1: New Insights and Interventions
Ruanne V. Barnabas, Connie Celum · 2012 · Current HIV Research
Antiretroviral prophylaxis: a defining moment in HIV control
Salim S. Abdool Karim, Quarraisha Abdool Karim · 2011 · The Lancet
Barriers and facilitators to pre-exposure prophylaxis (PrEP) eligibility screening and ongoing HIV testing among target populations in Bondo and Rarieda, Kenya: Results of a consultation with community stakeholders
Natasha Mack, Jacob O. Odhiambo, Christina Wong, Kawango E. Agot · 2014 · BMC Health Services Research
Pre-exposure prophylaxis 2.0: new drugs and technologies in the pipeline
Lara Esteves Coelho, Thiago Silva Torres, Valdilea Gonçalves Veloso, Raphael J. Landovitz, Beatriz Gilda Jegerhorn Grinsztejn · 2019 · The Lancet HIV
Manufacturing scale-up of electrospun poly(vinyl alcohol) fibers containing tenofovir for vaginal drug delivery
Emily A. Krogstad, Kim A. Woodrow · 2014 · International Journal of Pharmaceutics
Antiviral agents and HIV prevention
Myron S. Cohen, Kathryn Elizabeth Muessig, M. Kumi Smith, Kimberly A. Powers, Angela D. M. Kashuba · 2012 · AIDS
Design of Poly(lactic-co-glycolic Acid) (PLGA) Nanoparticles for Vaginal Co-Delivery of Griffithsin and Dapivirine and Their Synergistic Effect for HIV Prophylaxis
Haitao Yang, Jing Li, Sravan Kumar Patel, Kenneth E. Palmer, Bríd Devlin, Lisa Cencia Rohan · 2019 · Pharmaceutics
A 90-Day Tenofovir Reservoir Intravaginal Ring for Mucosal HIV Prophylaxis
Todd J. Johnson, Meredith R. Clark, Theodore H. Albright, Joel S. Nebeker, Anthony L. Tuitupou, Justin T. Clark, Judit Fabian, R. Tyler McCabe, Neelima Chandra, Gustavo F. Doncel et al. · 2012 · Antimicrobial Agents and Chemotherapy
Engineering a Segmented Dual-Reservoir Polyurethane Intravaginal Ring for Simultaneous Prevention of HIV Transmission and Unwanted Pregnancy
Justin T. Clark, Meredith R. Clark, Namdev B. Shelke, Todd J. Johnson, Eric M. Smith, Andrew K. Andreasen, Joel S. Nebeker, Judit Fabian, David R. Friend, Patrick F. Kiser · 2014 · PLoS ONE
Vaginal Langerhans Cells Nonproductively Transporting HIV-1 Mediate Infection of T Cells
Lamar Ballweber, Barry Robinson, Allison Kreger, Michael F. Fialkow, Gretchen M. Lentz, M. Juliana McElrath, Florian Hladik · 2011 · Journal of Virology
Reproductive Decision-Making and Periconception Practices Among HIV-Positive Men and Women Attending HIV Services in Durban, South Africa
Lynn T. Matthews, Tamaryn L. Crankshaw, Janet Giddy, Angela Kaida, Jennifer A. Smit, Norma C. Ware, David R. Bangsberg · 2011 · AIDS and Behavior
Advances and future perspectives in epithelial drug delivery
Yousuf Mohammed, Amy M. Holmes, Philip Chi Lip Kwok, Tushar Kumeria, Sarika Namjoshi, Mohammad Imran, Lana Matteucci, Masood Ali, Waiting Tai, Heather AE Benson et al. · 2022 · Advanced Drug Delivery Reviews
An Intravaginal Ring for the Simultaneous Delivery of Multiple Drugs
Marc M. Baum, Irina Butkyavichene, Joshua Gilman, Sean Kennedy, Etana G. Kopin, Amanda M. D. Malone, Cali Nguyen, Thomas J. Smith, David R. Friend, Meredith R. Clark et al. · 2012 · Journal of Pharmaceutical Sciences
Racial Differences and Correlates of Potential Adoption of Preexposure Prophylaxis
Gina M. Wingood, Kristin Dunkle, Christina M. Camp, Shilpa N. Patel, Julia E. Painter, Anna Rubtsova, Ralph Joseph DiClemente · 2013 · JAIDS Journal of Acquired Immune Deficiency Syndromes
Implementation Science of Pre-exposure Prophylaxis: Preparing for Public Use
Kristen Underhill, Don Operario, Matthew J. Mimiaga, Margie R. Skeer, Kenneth Hugh Mayer · 2010 · Current HIV/AIDS Reports
Pre-Exposure Prophylaxis and Antiretroviral Resistance: HIV Prevention at a Cost?
Christopher B. Hurt, Joe Eron, M. S. Cohen · 2011 · Clinical Infectious Diseases
Mucoadhesive nanosystems for vaginal microbicide development: friend or foe?
José das Neves, Mansoor M. Amiji, Bruno Filipe Carmelino Cardoso Sarmento · 2011 · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology
Formulation of tenofovir‐loaded functionalized solid lipid nanoparticles intended for HIV prevention
Dima Alukda, Timothy F. Sturgis, Bi-Botti Celestin Youan · 2011 · Journal of Pharmaceutical Sciences
Current status and future prospects of epidemiology and public health training and research in the WHO African region
Jean Bisimwa Nachega, Olalekan Abdulrahman Uthman, Yuh‐Shan Ho, Melanie W. Lo, Chuka Anude, Patrick Kalambayi Kayembe, Fred Wabwire‐Mangen, Exnevia Gomo, Papa Salif Sow, Ude Obike et al. · 2012 · International Journal of Epidemiology
The first decade of antiretroviral therapy in Africa
Nathan Paul Ford, Alexandra Calmy, Edward J. Mills · 2011 · Globalization and Health
A Multi-Compartment, Single and Multiple Dose Pharmacokinetic Study of the Vaginal Candidate Microbicide 1% Tenofovir Gel
Jill L. Schwartz, Wes Rountree, Angela D. M. Kashuba, Vivian Brache, Mitchell David Creinin, Alfred N. Poindexter, Brian P. Kearney · 2011 · PLoS ONE
Lost or just not following up
Chi-Chi N. Udeagu, Tashonna R. Webster, Angelica Bocour, Pierre Michel, Colin W. Shepard · 2013 · AIDS
The Potential Impact of Pre-Exposure Prophylaxis for HIV Prevention among Men Who Have Sex with Men and Transwomen in Lima, Peru: A Mathematical Modelling Study
Gabriela B. Gomez, Annick Bórquez, Carlos F. Cáceres, Eddy R. Segura, Robert M. Grant, Geoff P. Garnett, Timothy B. Hallett · 2012 · PLoS Medicine
Perspectives on HIV Prevention Among Urban Black Women: A Potential Role for HIV Pre-Exposure Prophylaxis
Charlene A. Flash, Valerie E. Stone, Jennifer Adelson Mitty, Matthew J. Mimiaga, Kathryn Tayo Hall, Douglas Krakower, Kenneth Hugh Mayer · 2014 · AIDS Patient Care and STDs
Electrospun fibers for vaginal anti-HIV drug delivery
Anna K. Blakney, Cameron Scott Ball, Emily A. Krogstad, Kim A. Woodrow · 2013 · Antiviral Research
HIV-1 Prevention for HIV-1 Serodiscordant Couples
Kathryn G. Curran, Jared M. Baeten, Thomas J. Coates, Ann Kurth, Nelly Mugo, Connie Celum · 2012 · Current HIV/AIDS Reports
The Cost-effectiveness of Pre-Exposure Prophylaxis for HIV Infection in South African Women
Rochelle P. Walensky, J.-E. Park, Robin Wood, Kenneth A. Freedberg, Callie A. Scott, Linda‐Gail Bekker, Elena Losina, Kenneth Hugh Mayer, George R. Seage, A. David Paltiel · 2012 · Clinical Infectious Diseases
State of the art in intravaginal ring technology for topical prophylaxis of HIV infection.
Patrick F. Kiser, Todd J. Johnson, Justin T. Clark · 2012 · PubMed
Virucidal activity of the dendrimer microbicide SPL7013 against HIV-1
Sushama Telwatte, Katie Moore, Adam Johnson, David P. Tyssen, Jasminka Sterjovski, Muriel Aldunate, Paul R. Gorry, Paul A. Ramsland, G.R. Lewis, Jeremy Ra Paull et al. · 2011 · Antiviral Research
Nanoparticles-in-film for the combined vaginal delivery of anti-HIV microbicide drugs
Cunha-Reis, Cassilda, Machado, Alexandra, Barreiros, Luísa, Araújo, Francisca, Nunes, Rute, Seabra, Vítor, Ferreira, Domingos, Segundo, Marcela A., Sarmento, Bruno, das Neves, José · 2016 · Journal of Controlled Release
Tenofovir 1% vaginal gel for prevention of HIV-1 infection in women in South Africa (FACTS-001): a phase 3, randomised, double-blind, placebo-controlled trial.
Delany-Moretlwe, Sinead, Lombard, Carl, Baron, Deborah, Bekker, Linda-Gail, Nkala, Busi, Ahmed, Khatija, Sebe, Modulakgotla, Brumskine, William, Nchabeleng, Maposhane, Palanee-Philips, Thesla et al. · 2018 · The Lancet Infectious Diseases
Early HIV‐1 Target Cells in Human Vaginal and Ectocervical Mucosa
Ruizhong Shen, Holly Elizabeth Richter, Phillip D. Smith · 2010 · American Journal of Reproductive Immunology
A long-acting integrase inhibitor protects female macaques from repeated high-dose intravaginal SHIV challenge
Chasity D. Andrews, Yun Lan Yueh, William R. Spreen, Leslie St. Bernard, Mar Boente-Carrera, Kristina Rodriguez, Agegnehu Gettie, Kasi Russell‐Lodrigue, James Blanchard, Susan L. Ford et al. · 2015 · Science Translational Medicine
Vaginal Challenge with an SIV-Based Dual Reporter System Reveals That Infection Can Occur throughout the Upper and Lower Female Reproductive Tract
Daniel J Stieh, Danijela Maric, Z. L. Kelley, Meegan R. Anderson, Holly Z. Hattaway, Beth Ann Beilfuss, Katharina B. Rothwangl, Ronald S. Veazey, Thomas J. Hope · 2014 · PLoS Pathogens
A dose-response relationship between exposure to a large-scale HIV preventive intervention and consistent condom use with different sexual partners of female sex workers in southern India
Kathleen Deering, Marie‐Claude Boily, Catherine M Lowndes, Jean Shoveller, MARK W. TYNDALL, Peter T. Vickerman, J.E. Bradley, Kaveri Gurav, Michael Pickles, Stephen Moses et al. · 2011 · BMC Public Health